Department of Medicine

HSR-Related News

"This study will aim to establish a longitudinal cohort of individuals across the life course — children, pregnant women, adults — who developed diabetes following SARS-CoV-2 infection in order to better understand the pathophysiology and clinical course of post-COVID-19 diabetes," says Jessica Harding, PhD. The study will be funded by the NIDDK.

After analyzing data from three southeastern states, a study led by Rachel Patzer, PhD, MPH, found that following the implementation of the national kidney allocation system (KAS) in 2014, access to early steps in the kidney transplant process increased for some patients.

Anant Madabhushi, PhD, a global leader in developing artificial intelligence to improve outcomes for individuals with cancer and other diseases, will join Emory School of Medicine in July 2022 as part of the university's growing research community focused on advancing AI to serve humanity.

The U.S. Food and Drug Administration has announced that molnupiravir, an oral antiviral drug invented by scientists at Emory University, has received Emergency Use Authorization (EUA) for treatment of COVID-19. Emory has discovered and advanced some of the world’s most important and valuable drugs such as belatacept for kidney transplants, Obizur for hemophilia, and Emtriva for HIV.

Recent Emory HSR Publications